BACKGROUND: The Patient-Reported Outcomes Measurement Information System (PROMIS(®)) is a new, state-of-the-art assessment system for measuring patient-reported health and well-being of adults and children that has the potential to be more valid, reliable and responsive than existing PROMs. The PROMIS items can be administered in short forms or, more efficiently, through computerized adaptive testing. This paper describes the translation of 563 items from 17 PROMIS item banks (domains) for adults from the English source into Dutch-Flemish. METHODS: The translation was performed by FACITtrans using standardized methodology and approved by the PROMIS Statistical Center. The translation included four forward translations, two back-translations, three to five independent reviews (at least two Dutch, one Flemish) and pre-testing in 70 adults (age range 20-77) from the Netherlands and Flanders. RESULTS: A small number of items required separate translations for Dutch and Flemish: physical function (five items), pain behaviour (two items), pain interference (one item), social isolation (one item) and global health (one item). Challenges faced in the translation process included: scarcity or overabundance of possible translations, unclear item descriptions, constructs broader/smaller in the target language, difficulties in rank ordering items, differences in unit of measurement, irrelevant items or differences in performance of activities. By addressing these challenges, acceptable translations were obtained for all items. CONCLUSION: The methodology used and experience gained in this study can be used as an example for researchers in other countries interested in translating PROMIS. The Dutch-Flemish PROMIS items are linguistically equivalent. Short forms will soon be available for use and entire item banks are ready for cross-cultural validation in the Netherlands and Flanders.
BACKGROUND: The Patient-Reported Outcomes Measurement Information System (PROMIS(®)) is a new, state-of-the-art assessment system for measuring patient-reported health and well-being of adults and children that has the potential to be more valid, reliable and responsive than existing PROMs. The PROMIS items can be administered in short forms or, more efficiently, through computerized adaptive testing. This paper describes the translation of 563 items from 17 PROMIS item banks (domains) for adults from the English source into Dutch-Flemish. METHODS: The translation was performed by FACITtrans using standardized methodology and approved by the PROMIS Statistical Center. The translation included four forward translations, two back-translations, three to five independent reviews (at least two Dutch, one Flemish) and pre-testing in 70 adults (age range 20-77) from the Netherlands and Flanders. RESULTS: A small number of items required separate translations for Dutch and Flemish: physical function (five items), pain behaviour (two items), pain interference (one item), social isolation (one item) and global health (one item). Challenges faced in the translation process included: scarcity or overabundance of possible translations, unclear item descriptions, constructs broader/smaller in the target language, difficulties in rank ordering items, differences in unit of measurement, irrelevant items or differences in performance of activities. By addressing these challenges, acceptable translations were obtained for all items. CONCLUSION: The methodology used and experience gained in this study can be used as an example for researchers in other countries interested in translating PROMIS. The Dutch-Flemish PROMIS items are linguistically equivalent. Short forms will soon be available for use and entire item banks are ready for cross-cultural validation in the Netherlands and Flanders.
Authors: William T Riley; Nan Rothrock; Bonnie Bruce; Christopher Christodolou; Karon Cook; Elizabeth A Hahn; David Cella Journal: Qual Life Res Date: 2010-07-01 Impact factor: 4.147
Authors: S A M Sikkes; E S M de Lange-de Klerk; Y A L Pijnenburg; P Scheltens; B M J Uitdehaag Journal: J Neurol Neurosurg Psychiatry Date: 2009-01 Impact factor: 10.154
Authors: Christian J Nelson; Christina Cho; Alexandra R Berk; Jimmie Holland; Andrew J Roth Journal: J Clin Oncol Date: 2009-12-07 Impact factor: 44.544
Authors: Martijn Ah Oude Voshaar; Peter M Ten Klooster; Erik Taal; Eswar Krishnan; Mart Afj van de Laar Journal: Arthritis Res Ther Date: 2012-03-05 Impact factor: 5.156
Authors: Jasper M Schellingerhout; Arianne P Verhagen; Martijn W Heymans; Bart W Koes; Henrica C de Vet; Caroline B Terwee Journal: Qual Life Res Date: 2011-07-07 Impact factor: 4.147
Authors: Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen Journal: Qual Life Res Date: 2014-11-16 Impact factor: 4.147
Authors: Jan van Bebber; Gerard Flens; Johanna T W Wigman; Edwin de Beurs; Sjoerd Sytema; Lex Wunderink; Rob R Meijer Journal: Int J Methods Psychiatr Res Date: 2018-09-24 Impact factor: 4.035
Authors: Nicholas E Johnson; Anne-Berit Ekstrom; Craig Campbell; Man Hung; Heather R Adams; Wei Chen; Elizabeth Luebbe; James Hilbert; Richard T Moxley; Chad R Heatwole Journal: Dev Med Child Neurol Date: 2015-10-28 Impact factor: 5.449
Authors: Polake Rawang; Prawit Janwantanakul; Helena Correia; Mark P Jensen; Rotsalai Kanlayanaphotporn Journal: Qual Life Res Date: 2019-11-13 Impact factor: 4.147
Authors: J Devine; L A Schröder; F Metzner; F Klasen; J Moon; M Herdman; M P Hurtado; G Castillo; A C Haller; H Correia; C B Forrest; U Ravens-Sieberer Journal: Qual Life Res Date: 2018-05-15 Impact factor: 4.147
Authors: Hilde M Wesselius; Eva S van den Ende; Jelmer Alsma; Jan C Ter Maaten; Stephanie C E Schuit; Patricia M Stassen; Oscar J de Vries; Karin H A H Kaasjager; Harm R Haak; Frederiek F van Doormaal; Jacobien J Hoogerwerf; Caroline B Terwee; Peter M van de Ven; Frank H Bosch; Eus J W van Someren; Prabath W B Nanayakkara Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873
Authors: Erik-Jan A Haan; Caroline B Terwee; Marieke F Van Wier; Nienke W Willigenburg; Derek F P Van Deurzen; Martijn F Pisters; Aaron J Kaat; Leo D Roorda Journal: Qual Life Res Date: 2020-01-01 Impact factor: 4.147
Authors: Maud M van Muilekom; Michiel A J Luijten; Hedy A van Oers; Caroline B Terwee; Raphaële R L van Litsenburg; Leo D Roorda; Martha A Grootenhuis; Lotte Haverman Journal: J Patient Rep Outcomes Date: 2021-07-10